Literature DB >> 24171706

Formulation and evaluation of mucoadhesive microspheres of tenofovir disoproxil fumarate for intravaginal use.

Arshad Bashir Khan, Ram Sharnagat Thakur1.   

Abstract

Intravaginal mucoadhesive microspheres of tenofovir disoproxil fumarate (TDF) has been formulated using chitosan as the matrix-forming mucoadhesive polymer and evaluated. Ionotropic gelation method was used to produce the microspheres. Drug-polymer compatibility, percentage yield, particle size determination by optical microscopy, drug content & encapsulation efficiency, ex vivo mucoadhesion and in vitro release were evaluated. Based on the evaluation studies, F6 was selected as the best formulation and evaluated further for release kinetics and curve fitting analysis. F6 followed Korsmeyer-Peppas and Higuchi models. Accelerated stability study was conducted as per ICH guidelines. Drug content analysis, FTIR, XRD, SEM analysis showed that it remained stable for a period of six months.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24171706     DOI: 10.2174/156720181000131028120709

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  3 in total

1.  Mucoadhesive Microspheres of Maraviroc and Tenofovir Designed for Pre-Exposure Prophylaxis of HIV-1: An in vitro Assessment of the Effect on Vaginal Lactic Acid Bacteria Microflora.

Authors:  Sabdat O Ekama; Margaret O Ilomuanya; Chukwuemeka P Azubuike; Tajudeen A Bamidele; Muinah A Fowora; Oluwagbemiga O Aina; Oliver C Ezechi; Cecilia I Igwilo
Journal:  HIV AIDS (Auckl)       Date:  2021-04-08

Review 2.  Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications.

Authors:  Randy Chi Fai Cheung; Tzi Bun Ng; Jack Ho Wong; Wai Yee Chan
Journal:  Mar Drugs       Date:  2015-08-14       Impact factor: 5.118

3.  A Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo Models.

Authors:  Sandhya Boyapalle; Weidong Xu; Payal Raulji; Subhra Mohapatra; Shyam S Mohapatra
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.